ATR inhibition preferentially targets homologous recombination-deficient tumor cells

  • M. Krajewska
  • , R. S.N. Fehrmann
  • , P. M. Schoonen
  • , S. Labib
  • , E. G.E. De Vries
  • , L. Franke
  • , M. A.T.M. Van Vugt

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'ATR inhibition preferentially targets homologous recombination-deficient tumor cells'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology